Stock GMAB GENMAB A/S
Add to a list

Calendar Genmab A/S

Equities

GMAB

DK0010272202

Biotechnology & Medical Research

Market Closed - Nasdaq Copenhagen
Other stock markets
 09:50:00 04/12/2025 pm IST 		5-day change 1st Jan Change
2,062.00 DKK +1.93% Intraday chart for Genmab A/S +1.53% +38.16%
05/12 Genmab A/S Presents at Citi Annual Global Healthcare Conference 2025, Dec-04-2025 09:45 AM
04/12 Genmab Closes $2.5 Billion Senior Notes Offering MT

Chart calendar Genmab A/S

c468daf4590b2d.TZsQhXui--0m6u-NbvLVEX6L0ZqTbiQizIPWcnD3aK8.dct86T7Vk6JQpZfiLcGAYkjdkM_7WlEbha6ORT6hXJw49lj1GNuQqFeerg~57ce80de300723d1e84a8c6dfb102ee6

Upcoming events on Genmab A/S

06/12/2025

American Society of Hematology Meeting - Abstract Number:7251

Add to your calendar

Google
Apple
ICS format
06/12/2025

American Society of Hematology Meeting - Abstract Number:8075

Add to your calendar

Google
Apple
ICS format
06/12/2025

American Society of Hematology Meeting - Abstract Number:7942

Add to your calendar

Google
Apple
ICS format
06/12/2025

American Society of Hematology Meeting - Abstract No:63

Add to your calendar

Google
Apple
ICS format
06/12/2025

American Society of Hematology Meeting - Abstract No:64

Add to your calendar

Google
Apple
ICS format
07/12/2025

American Society of Hematology Meeting - Abstract No:1820

Add to your calendar

Google
Apple
ICS format
07/12/2025

American Society of Hematology Meeting - Abstract No:1955

Add to your calendar

Google
Apple
ICS format
07/12/2025

American Society of Hematology Meeting - Abstract No:1959

Add to your calendar

Google
Apple
ICS format
07/12/2025

American Society of Hematology Meeting - Abstract No:1960

Add to your calendar

Google
Apple
ICS format
07/12/2025

American Society of Hematology Meeting - Abstract No:2721

Add to your calendar

Google
Apple
ICS format
07/12/2025

American Society of Hematology Meeting - Abstract No:3565

Add to your calendar

Google
Apple
ICS format
07/12/2025

American Society of Hematology Meeting - Abstract No:464

Add to your calendar

Google
Apple
ICS format
07/12/2025

American Society of Hematology Meeting - Abstract No:465

Add to your calendar

Google
Apple
ICS format
07/12/2025

American Society of Hematology Meeting - Abstract No:466

Add to your calendar

Google
Apple
ICS format
08/12/2025

American Society of Hematology Meeting - Abstract No:3736

Add to your calendar

Google
Apple
ICS format

Past events on Genmab A/S

04/12/2025

Citi Global Healthcare Conference

19/11/2025

Jefferies Global Healthcare Conference

06/11/2025

Q3 2025 Earnings Call

06/11/2025

Q3 2025 Earnings Release

29/09/2025

Acquisition of Merus by Genmab Call

23/09/2025

Bank of America Global Healthcare Conference

09/09/2025

Morgan Stanley Global Healthcare Conference

07/08/2025

Q2 2025 Earnings Call

07/08/2025

Q2 2025 Earnings Release

17/06/2025

International Malignant Lymphoma Conference

15/06/2025

European Hematology Association Congress - Abstract Number: S247

15/06/2025

European Hematology Association Congress - Abstract Number: S245

15/06/2025

European Hematology Association Congress - Abstract Number S245

14/06/2025

European Hematology Association Congress - Abstract Number: PS1912

14/06/2025

European Hematology Association Congress - Abstract Number: PS1886

14/06/2025

European Hematology Association Congress - Abstract Number: PS1898

14/06/2025

European Hematology Association Congress - Abstract Number: PS1944

14/06/2025

European Hematology Association Congress - Abstract Number: PS1942

14/06/2025

European Hematology Association Congress - Abstract Number: PS1932

14/06/2025

European Hematology Association Congress - Abstract Number: PS1968

Annual results

Fiscal PeriodDecember 2022 2023 2024 2025 2026 2027
Net sales
Million DKK		Released
Forecast
Spread 		14 595
14 068
3.75%		16 474
16 380
0.58%		21 526
21 279
1.16%
23 889


27 616


31 528

EBITDA
Million DKK		Released
Forecast
Spread 		6 719
6 371
5.46%		5 616
5 721
-1.83%		7 116
6 933
2.64%
9 002


10 480


13 376

EBIT
Million DKK		Released
Forecast
Spread 		6 357
6 008
5.81%		5 321
5 398
-1.42%		7 003
6 441
8.72%
8 433


9 103


11 693

Earnings before Tax (EBT)
Million DKK		Released
Forecast
Spread 		7 035
8 905
-21%		5 637
6 236
-9.6%		9 164
7 451
22.98%
9 480


9 358


12 034

Net income
Million DKK		Released
Forecast
Spread 		5 522
6 793
-18.71%		4 352
4 989
-12.77%		7 844
5 544
41.48%
7 505


6 921


9 374

EPS
DKK		Released
Forecast
Spread 		83,7
103
-18.98%		66,0
76,1
-13.23%		121
85,7
41.66%
117


106


143

Announcement Date22/02/2314/02/2412/02/25-

Quarterly results

Fiscal PeriodJune 2023 Q4 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4
Net sales
Million DKK		Released
Forecast
Spread 		4 678
4 610
1.48%		4 143
3 989
3.86%		5 402
4 959
8.94%		9 545
9 039
5.6%		5 540
5 646
-1.89%		6 441
6 391
0.79%		4 731
5 019
-5.73%		5 934
5 812
2.11%		6 613
6 373
3.77%
6 585


5 976


6 819


7 443


6 917

EBITDA
Million DKK		Released
Forecast
Spread 		1 899
1 804
5.28%		823
880
-6.45%		1 804
1 571
14.84%		2 627
2 412
8.91%		2 129
1 847
15.25%		2 275
1 966
15.72%		1 350
986
36.95%		2 412
2 207
9.32%		3 087
2 871
7.51%
2 301


2 809


3 240


4 215




EBIT
Million DKK		Released
Forecast
Spread 		1 670
1 772
-5.73%		801
832
-3.68%		1 640
1 599
2.57%		2 441
2 229
9.51%		2 102
1 782
17.95%		2 191
1 945
12.67%		1 244
1 069
16.32%		2 310
2 074
11.36%		2 970
2 445
21.46%
2 212


2 334


2 782


3 773




Earnings before Tax (EBT)
Million DKK		Released
Forecast
Spread 		926
1 888
-50.95%		1 716
1 064
61.28%		2 127
1 847
15.15%		3 843
3 374
13.9%		1 719
1 761
-2.38%		3 602
2 037
76.79%		1 615
1 214
32.96%		2 714
2 174
24.81%		3 119
2 491
25.22%
2 284













Net income
Million DKK		Released
Forecast
Spread 		640
1 439
-55.52%		1 325
833
59.07%		1 408
1 426
-1.28%		2 733
2 598
5.2%		1 266
1 373
-7.77%		3 845
1 606
139.45%		1 290
1 068
20.84%		2 156
1 657
30.06%		2 595
1 927
34.67%
1 706













EPS
DKK		Released
Forecast
Spread 		9,67
22,3
-56.65%		20,2
12,9
56.06%		21,7
21,8
-0.34%		41,9
39,5
5.92%		19,8
21,3
-6.93%		59,6
25,0
138.85%		20,2
16,0
26.14%		34,8
24,5
42.1%		41,8
30,3
37.77%
27,4


14,8


14,6


20,7


22,6

Announcement Date14/02/2402/05/2408/08/2408/08/2406/11/2412/02/2508/05/2507/08/2506/11/25-----

Upcoming sector events for Genmab A/S

15/12/2025
SANBIO COMPANY LIMITED Stock SanBio Company Limited

Q3 2025 Earnings Release

Add to your calendar

Google
Apple
ICS format
15/01/2026
BIOCON LIMITED Stock Biocon Limited

Q3 2026 Earnings Release (Projected)

Add to your calendar

Google
Apple
ICS format
05/02/2026
GENMAB A/S Stock Genmab A/S

Q4 2025 Earnings Release

Add to your calendar

Google
Apple
ICS format
05/02/2026
ANAVEX LIFE SCIENCES CORP. Stock Anavex Life Sciences Corp.

Q1 2026 Earnings Release (Projected)

Add to your calendar

Google
Apple
ICS format
10/02/2026
EXELIXIS, INC. Stock Exelixis, Inc.

Q4 2025 Earnings Release (Projected)

Add to your calendar

Google
Apple
ICS format
10/02/2026
ARROWHEAD PHARMACEUTICALS, INC. Stock Arrowhead Pharmaceuticals, Inc.

Q1 2026 Earnings Release (Projected)

Add to your calendar

Google
Apple
ICS format
11/02/2026
VIKING THERAPEUTICS, INC. Stock Viking Therapeutics, Inc.

Q4 2025 Earnings Release (Projected)

Add to your calendar

Google
Apple
ICS format
11/02/2026
REZOLUTE, INC. Stock Rezolute, Inc.

Q2 2026 Earnings Release (Projected)

Add to your calendar

Google
Apple
ICS format
12/02/2026
AGIOS PHARMACEUTICALS, INC. Stock Agios Pharmaceuticals, Inc.

Q4 2025 Earnings Release (Projected)

Add to your calendar

Google
Apple
ICS format
12/02/2026
PROTHENA CORPORATION PLC Stock Prothena Corporation plc

Q4 2025 Earnings Release (Projected)

Add to your calendar

Google
Apple
ICS format
More events

Past sector events for Genmab A/S

04/12/2025
KALVISTA PHARMACEUTICALS, INC. Stock KalVista Pharmaceuticals, Inc.

Q2 2026 Earnings Release (Projected)

26/11/2025
ARROWHEAD PHARMACEUTICALS, INC. Stock Arrowhead Pharmaceuticals, Inc.

Q4 2025 Earnings Release

22/11/2025
INVENTIVA Stock Inventiva

Q3 2025 Sales and Revenue Release

17/11/2025
IMMATICS N.V. Stock Immatics N.V.

Q3 2025 Earnings Release

14/11/2025
SCHOLAR ROCK HOLDING CORPORATION Stock Scholar Rock Holding Corporation

Q3 2025 Earnings Release

14/11/2025
ORUM THERAPEUTICS, INC. Stock Orum Therapeutics, Inc.

Q3 2025 Earnings Release

14/11/2025
D&D PHARMATECH INC. Stock D&D Pharmatech Inc.

Q3 2025 Earnings Release

14/11/2025
OLIX PHARMACEUTICALS, INC Stock OliX Pharmaceuticals, Inc

Q3 2025 Earnings Release

14/11/2025
PEPTRON, INC. Stock Peptron, Inc.

Q3 2025 Earnings Release

14/11/2025
LIGACHEM BIOSCIENCES INC. Stock LigaChem Biosciences Inc.

Q3 2025 Earnings Release

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. GMAB Stock
  4. Calendar Genmab A/S

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States
United-States
Canada
Canada

MIDDLE EAST

Saudi Arabia
Saudi Arabia
United Arab Emirates
United Arab Emirates

EUROPE

France
France
Deutschland
Deutschland
Suisse
Suisse
Schweiz
Schweiz
Italia
Italia
Österreich
Österreich
België
België
Nederland
Nederland
España
España
Sverige
Sverige
United Kingdom
United Kingdom

APAC

Australia
Australia
India
India
Hong Kong
Hong Kong
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition